TY - JOUR
T1 - Synthesis of a boron-containing amidoxime reagent and its application to synthesize functionalized oxadiazole and quinazolinone derivatives
AU - Das, Bhaskar C.
AU - Nandwana, Nitesh K.
AU - P.Ojha, Devi
AU - Das, Sasmita
AU - Evans, Todd
N1 - Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/3/2
Y1 - 2022/3/2
N2 - Herein, we report the design, synthesis and application of a borylated amidoxime reagent for the direct synthesis of functionalized oxadiazole and quinazolinone derivatives. This reagent exhibits broad synthetic utility to obtain a variety of biologically relevant drug-like molecules. It can be easily prepared at large scale from relatively inexpensive reagents, and can undergo facile transformations to obtain target compounds. The developed amidoxime reagent was synthesized from 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile and hydroxyl amine hydrochloride using N,N-diisopropylethylamine as a base in ethanol under reflux conditions. Overall advantages include a metal-free route to boronated oxadiazoles, quinazolinone derivatives, and restriction of the multistep sequences. Importantly, the boron-rich pharmacophore derived compounds were obtained through an efficient and inexpensive strategy.
AB - Herein, we report the design, synthesis and application of a borylated amidoxime reagent for the direct synthesis of functionalized oxadiazole and quinazolinone derivatives. This reagent exhibits broad synthetic utility to obtain a variety of biologically relevant drug-like molecules. It can be easily prepared at large scale from relatively inexpensive reagents, and can undergo facile transformations to obtain target compounds. The developed amidoxime reagent was synthesized from 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile and hydroxyl amine hydrochloride using N,N-diisopropylethylamine as a base in ethanol under reflux conditions. Overall advantages include a metal-free route to boronated oxadiazoles, quinazolinone derivatives, and restriction of the multistep sequences. Importantly, the boron-rich pharmacophore derived compounds were obtained through an efficient and inexpensive strategy.
KW - Boron based Therapeutics
KW - Boron containing amidoxime
KW - Imidazo[1,2-a]pyridine
KW - Oxadiazoles
KW - Quinazolinone
UR - http://www.scopus.com/inward/record.url?scp=85123897480&partnerID=8YFLogxK
U2 - 10.1016/j.tetlet.2022.153657
DO - 10.1016/j.tetlet.2022.153657
M3 - Article
AN - SCOPUS:85123897480
SN - 0040-4039
VL - 92
JO - Tetrahedron Letters
JF - Tetrahedron Letters
M1 - 153657
ER -